Ignite Creation Date:
2025-12-24 @ 4:25 PM
Ignite Modification Date:
2026-02-20 @ 12:46 PM
Study NCT ID:
NCT02103166
Status:
SUSPENDED
Last Update Posted:
2016-08-19
First Post:
2014-04-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Role of Hyoscine Bromide in Latent and Active Labor
Sponsor:
Hospital Clinic of Barcelona
Organization:
Study Overview
Official Title:
Randomized, Masked, Placebo-controlled Clinical Trial to Evaluate the Effects of a Single Intravenous Dose of Hyoscine Bromide on the Duration and Pain in Latent and Active Labor
Status:
SUSPENDED
Status Verified Date:
2016-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Conditions of recruitment changed
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether hyoscine bromide decreases the duration of the active phase of labor.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: